Protecting Life Sciences' Sensitive Data
In recent years, the Cybersecurity landscape has undergone a seismic shift in terms of new technologies, challenges, and threats. The hybrid work environment, digitization of everything, and ubiquitous computing, fueled by an explosion of data, have all contributed to an exponentially more complex and exposed IT environment. An increase in recent, high profile ransomware incidents have made Cybersecurity a Boardroom issue, and it's no longer the CISO's job alone to defend the Enterprise. The adage, "It's not a matter of IF your company gets hacked, it's a matter of WHEN," is now passe. The IDC (International Data Corporation) predicts that by 2025, various cloud services will have accumulated 175 zettabytes of data globally including business and personal financial information, health records, social media, and other private data. This means that by 2025, the cost of international cyberattacks could reach the $10.5 Trillion mark.
Life Sciences organizations have long been the targets of cyber-attacks as many cybercriminals are looking to steal their confidential information such as intellectual property, clinical studies, drug formulation, pricing and contracts, patient information, and other sensitive data. Today, third-party vendors, shared platforms, and tools are pervasive in the industry, especially for mission critical projects like drug development and clinical trials. If even one of these vendors is breached, it can lead to vulnerability and catastrophic damage for all the partners. During the past two decades, Mergers and Acquisitions (M&A) have increasingly dominated and defined the industry, a trend that will continue or likely accelerate for the foreseeable future. M&A activity itself poses a potential, and significant Cybersecurity risk. Target companies and subsidiaries may not have invested in their security to the extent that the larger, parent companies have. Consequently, security teams are continuously adapting to defend against these new challenges and threats.
At Coforge, we are rethinking Cybersecurity. Coforge focuses on the intersect of domain expertise and emerging technologies. That means our Cybersecurity services are multi-dimensional, integrated, platform-based, and Industry-specific to address the threats that are distinct to each domain in the Life Sciences value-chain. Our perspective is that while it is practically impossible to prevent a breach, it is entirely possible to protect your data. Our approach is based on FIPS (Federal Information Processing Standard) 140-3 validated security, which is critically important for your mobile, web, and IoT/MIoT data security. By replacing each piece of data in transit with random streams of instantly obsolete data values, we provide full data immutability, and a level of security that is unparalleled in the industry.